Valneva SE ( INRLF) - Key Metrics
INRLF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.27 | -$0.29 | -$0.24 | -$0.24 |
| 2025Q3 | $0.18 | -$0.27 | -$0.11 | -$0.11 |
| 2025Q2 | $0.30 | -$0.07 | -$0.02 | -$0.02 |
| 2025Q1 | $0.32 | -$0.06 | -$0.05 | -$0.06 |
INRLF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -3.22 |
| 2025Q3 | ? | -4.53 |
| 2025Q2 | ? | -8.23 |
| 2025Q1 | ? | -12.88 |
INRLF
Price: $2.58
52 week price:
Earnings Per Share: -0.93 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 519.6 million